IF by specialty › Hematology
Arteriosclerosis, Thrombosis, and Vascular Biology — Impact Factor
The 2025 Impact Factor of Arteriosclerosis, Thrombosis, and Vascular Biology is 8.8 (Q1 in Hematology; subscription or hybrid).
- Impact Factor
- 8.8 JCR 2025
- JCR category
- Hematology
- Quartile
- Q1 in Hematology
- Publisher
- Wolters Kluwer (American Heart Association)
- Open access
- subscription or hybrid
- IF source
- ahajournals.org
Position within the field
Ranked 10 of the 38 journals in Hematology on this site (top 50%).
Hematology journals with a similar Impact Factor
- HemaSphere IF 11.3
- American Journal of Hematology IF 9.4
- Leukemia IF 8.8
- Haematologica IF 8.2
- Blood Advances IF 7.7
- Blood Reviews IF 7.2
About this value
The Journal Impact Factor of Arteriosclerosis, Thrombosis, and Vascular Biology (JCR 2025, released June 2026) is 8.8. Values are compiled by cross-checking figures published by publishers and societies against public aggregators; this is not a reproduction of Clarivate Journal Citation Reports™. Confirm the current value on the publisher's page or in JCR before deciding where to submit. The quartile (Q1–Q4) is the journal's relative position within its JCR category; Q1 means the top 25%.
Last updated September 2026. Report errors via the contact form. Other journals in the same category: Hematology.